Quarterly report [Sections 13 or 15(d)]

Unaudited Interim Condensed Consolidated Statements of Cash Flows

v3.26.1
Unaudited Interim Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash Flows From Operating Activities:    
Net loss $ (8,362) $ (7,236)
Adjustments to reconcile net loss to net cash and restricted cash used in operating activities:    
Change in gain on sale of business 344 0
Depreciation and amortization 11,575 3,473
Stock-based compensation 8,741 9,566
Change in fair value of warrant liabilities (1,530) (2,829)
Change in fair value of other assets and liabilities 2,066 0
Accretion of interest income on held-to-maturity securities (446) (1,508)
Deferred tax expense (benefit) (96) 4
Non-cash capital contribution 333 0
Other 126 428
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (194) (1,650)
Accounts receivable (517) (6,777)
Other non-current assets 77 74
Operating right-of-use assets/lease liabilities 115 (61)
Accounts payable and accrued expenses (2,645) 914
Deferred revenue (15) 2,292
Net cash provided by / (used in) operating activities 9,572 (3,310)
Cash Flows From Investing Activities:    
Acquisitions, net of cash acquired (34,823) 0
Cash transfer related to sale of business (290) 0
Capitalized software development costs (616) (961)
Purchase of property and equipment, net of proceeds from disposal (7,669) (4,849)
Purchase of held-to-maturity investments (6,254) (96,403)
Proceeds from maturities of held-to-maturity investments 30,500 151,300
Net cash (used in) / provided by investing activities (includes discontinued operations; see Note 5) (19,152) 49,087
Cash Flows From Financing Activities:    
Proceeds from the exercise of common stock options 55 74
Taxes paid related to net share settlement of equity awards (4,788) (5,457)
Payments for debt issuance costs (338) 0
Net cash used in financing activities (5,071) (5,383)
Effect of foreign exchange rate changes on cash balances 0 277
Net (decrease) / increase in cash and cash equivalents and restricted cash (14,651) 40,671
Cash and cash equivalents and restricted cash - beginning 31,232 19,647
Cash and cash equivalents and restricted cash - ending 16,581 60,318
Reconciliation to consolidated balance sheets    
Cash and cash equivalents 16,317 58,754
Restricted cash 264 1,564
Total cash and cash equivalents and restricted cash 16,581 60,318
Supplemental cash flow information    
Income Taxes paid 93 23
Non-cash investing and financing activities:    
New leases under ASC 842 entered into during the period 1,317 1,200
Common stock issued for acquisition 4,267 0
Consideration payable in other current liabilities 2,950 0
Purchases of property and equipment and capitalized software in accounts payable and accrued expenses $ 59 $ 234